No Association Between Irs-1 Promoter Methylation And Type 2 Diabetes

Jiangbo Ma,Jia Cheng,Lingyan Wang,Hongwei Wang,Leiting Xu,Panpan Liu,Shizhong Bu,Lina Zhang,Yanping Le,Meng Ye,Qinwen Wang,Yuping Shi,Shiwei Duan

DOI: https://doi.org/10.3892/mmr.2013.1569

IF: 3.423

2013-01-01

Molecular Medicine Reports

Abstract:As a candidate gene for type 2 diabetes (T2D), insulin receptor substrate-1 (IRS-1) gene variations were found to be associated with the risk of T2D. The aim of our study was to investigate the contribution of promoter DNA methylation of the IRS-1 gene to the risk of T2D. Using bisulphite pyrosequencing technology, the DNA methylation levels of 3 CpG dinucleotides within the IRS-1 gene promoter were measured in 48 T2D patients and 48 age- and gender-matched healthy controls. Our results indicated that there was no significant association between the methylation of the IRS-1 gene promoter and the risk of T2D (P>0.1). A breakdown analysis by gender revealed that IRS-1 promoter methylation was not associated with an increased risk of T2D for either gender (P>0.1), although there were significantly lower methylation levels of CpG1 (P=0.002) and CpG2 (P=0.043) within the IRS-1 gene promoter in males than in females.